CervoMed Inc. (CRVO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 1.5M 3M 4.5M Q2 '10: 0 Q1 '11: 0 Q2 '11: 0 Q3 '11: 250.2K Q4 '11: 320.3K Q1 '12: 159.5K Q2 '12: 143.3K Q3 '12: 143.3K Q4 '12: 0 Q1 '13: 0 Q2 '13: 71.7K Q3 '13: 0 Q4 '13: 0 Q1 '14: 0 Q3 '22: 0 Q4 '22: 0 Q1 '23: 1.4M Q2 '23: 1.7M Q3 '23: 1.5M Q4 '23: 2.5M Q1 '24: 2.3M Q2 '24: 3.3M Q3 '24: 1.9M Q4 '24: 2.2M Q1 '25: 1.9M Q2 '25: 1.8M Q3 '25: 322.6K Q4 '25: 8.7K Q1 '26: 0 Q2 '26: 0 Q1 '11 Q1 '12 Q1 '13 Q1 '14 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Gross Profit Quarterly

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q2 '10: 0 Q1 '11: 0 Q2 '11: 0 Q3 '11: -3.6K Q4 '11: -1.7M Q1 '12: -69K Q2 '12: 142.5K Q3 '12: 142.5K Q4 '12: 0 Q1 '13: 0 Q2 '13: 71.7K Q3 '13: 0 Q4 '13: 0 Q1 '14: 0 Q1 '11 Q3 '11 Q1 '12 Q3 '12 Q1 '13 Q3 '13 Q1 '14

Operating Income Quarterly

-15M -10M -5M 0 5M 10M 15M Q1 '10: -1.2M Q2 '10: -1.8M Q3 '10: -1.6M Q4 '10: -3M Q1 '11: -1.7M Q2 '11: -2.1M Q3 '11: -4.1M Q4 '11: -8.6M Q1 '12: -2.4M Q2 '12: -3.4M Q3 '12: -3.4M Q4 '12: -3.6M Q1 '13: -2.1M Q2 '13: -8.1M Q3 '13: -1.7M Q4 '13: -942.7K Q1 '14: -1.4M Q2 '14: -1.8M Q3 '14: -3.5M Q4 '14: -7.9M Q1 '15: -1.2M Q2 '15: -1.3M Q3 '15: -1.3M Q4 '15: -2.6M Q1 '16: -6.2M Q2 '16: -3.8M Q3 '16: -5.8M Q4 '16: -2.5M Q1 '17: -2.6M Q2 '17: -3M Q3 '17: -3.3M Q4 '17: -2.5M Q1 '18: -3.4M Q2 '18: -3.1M Q3 '18: -7M Q4 '18: -5.6M Q1 '19: -2.9M Q2 '19: -2.6M Q3 '19: -3.1M Q4 '19: -3M Q1 '20: 3M Q2 '20: -3.7M Q3 '20: -5.3M Q4 '20: -4.1M Q1 '21: -4.7M Q2 '21: -3.8M Q3 '21: -12.7M Q4 '21: -3.5M Q1 '22: -4.6M Q2 '22: -4.2M Q3 '22: -904.1K Q4 '22: 6.2M Q1 '23: -1.4M Q2 '23: -1.2M Q3 '23: -2.7M Q4 '23: -2.5M Q1 '24: -2.6M Q2 '24: -3M Q3 '24: -5.4M Q4 '24: -7.2M Q1 '25: -5.3M Q2 '25: -6.6M Q3 '25: -8M Q4 '25: -8.3M Q1 '26: -8.1M Q2 '26: -6.7M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Net Income Quarterly

-30M -20M -10M 0 10M 20M 30M Q1 '10: -1.7M Q2 '10: -1.8M Q3 '10: -1.8M Q4 '10: -3M Q1 '11: -1.7M Q2 '11: -2.1M Q3 '11: -4.3M Q4 '11: -14.4M Q1 '12: -291K Q2 '12: -1.3M Q3 '12: -3.5M Q4 '12: -1.8M Q1 '13: -2.5M Q2 '13: 2.3M Q3 '13: -1.5M Q4 '13: -803.4K Q1 '14: -1.4M Q2 '14: -4.5M Q3 '14: -3.4M Q4 '14: -5.1M Q1 '15: -1.2M Q2 '15: -1.3M Q3 '15: -1.4M Q4 '15: -2.7M Q1 '16: -6.2M Q2 '16: -3.8M Q3 '16: -5.4M Q4 '16: -2.6M Q1 '17: -28.6M Q2 '17: 20.4M Q3 '17: 5.1M Q4 '17: 1.8M Q1 '18: -3.3M Q2 '18: -2.8M Q3 '18: -6.7M Q4 '18: -5.6M Q1 '19: -2.7M Q2 '19: -2.5M Q3 '19: -2.8M Q4 '19: -3.8M Q1 '20: -2.6M Q2 '20: -3.1M Q3 '20: -4.4M Q4 '20: -4.1M Q1 '21: -4.6M Q2 '21: -3.8M Q3 '21: -12.2M Q4 '21: -3.5M Q1 '22: -4.5M Q2 '22: -4.2M Q3 '22: -882.6K Q4 '22: 3.8M Q1 '23: -534.3K Q2 '23: -1.4M Q3 '23: 2.2M Q4 '23: -2.4M Q1 '24: -2.5M Q2 '24: -2.3M Q3 '24: -4.8M Q4 '24: -6.7M Q1 '25: -4.9M Q2 '25: -6.3M Q3 '25: -7.7M Q4 '25: -8.1M Q1 '26: -8M Q2 '26: -6.6M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

0 700K 1.4M 2.1M Q2 '10: 0 Q1 '11: 0 Q2 '11: 0 Q3 '11: 253.8K Q4 '11: 2.1M Q1 '12: 228.5K Q2 '12: 850 Q3 '12: 850 Q4 '12: 0 Q1 '13: 0 Q2 '13: 0 Q3 '13: 0 Q4 '13: 0 Q1 '14: 0 Q1 '11 Q3 '11 Q1 '12 Q3 '12 Q1 '13 Q3 '13 Q1 '14

Operating Cash Flow Quarterly

-9M -6M -3M 0 3M 6M 9M Q3 '10: -741.9K Q4 '10: -391K Q3 '11: -4.5M Q4 '11: -3.2M Q1 '12: -1.8M Q2 '12: -407.3K Q3 '12: -559.3K Q4 '12: -1.5M Q1 '13: -400.7K Q2 '13: -450.3K Q3 '13: -333K Q4 '13: -633 Q1 '14: -432.9K Q2 '14: -4.7M Q3 '14: -2M Q4 '14: -1.9M Q1 '15: -938.8K Q2 '15: -998.8K Q3 '15: -981.7K Q4 '15: -2.3M Q1 '16: -4.6M Q2 '16: -2.9M Q3 '16: -1.9M Q4 '16: -1.4M Q1 '17: -3.4M Q2 '17: -2.7M Q3 '17: -3.9M Q4 '17: -2.3M Q1 '18: -3.3M Q2 '18: -2.5M Q3 '18: -1.9M Q4 '18: -3M Q1 '19: -2.7M Q2 '19: -2.6M Q3 '19: -2.2M Q4 '19: -2.4M Q1 '20: -3.5M Q2 '20: -3.1M Q3 '20: -3.5M Q4 '20: -3.4M Q1 '21: -5.2M Q2 '21: -3.3M Q3 '21: -3M Q4 '21: -3M Q1 '22: -4.7M Q2 '22: -4M Q3 '22: 6.9M Q4 '22: -692.5K Q1 '23: -1.5M Q2 '23: -2M Q3 '23: -1.5M Q4 '23: -2.5M Q1 '24: -1.4M Q2 '24: -2.2M Q3 '24: -4.9M Q4 '24: -8.1M Q1 '25: -3.9M Q2 '25: -6.5M Q3 '25: -6.5M Q4 '25: -6.6M Q1 '26: -8M Q2 '26: -6.9M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q1 '15: -941K Q2 '15: -1M Q3 '15: -984.4K Q4 '15: -2.3M Q1 '16: -4.6M Q2 '16: -2.9M Q3 '16: -1.9M Q4 '16: -1.4M Q1 '17: -3.4M Q2 '17: -2.8M Q3 '17: -4.3M Q4 '17: -2.3M Q2 '15 Q4 '15 Q2 '16 Q4 '16 Q2 '17 Q4 '17

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q2 '10: 60.8M Q3 '10: 62.5M Q2 '11: 71.2M Q3 '11: 77.5M Q1 '12: 109.4M Q2 '12: 117.9M Q3 '12: 89.7M Q1 '13: 1.2M Q2 '13: 2.9M Q3 '13: 4.1M Q1 '14: 5.9M Q2 '14: 12.9M Q3 '14: 18.7M Q1 '15: 18.6M Q2 '15: 18.6M Q3 '15: 18.6M Q2 '16: 10.3M Q3 '16: 10.3M Q2 '17: 13.9M Q3 '17: 14.7M Q2 '18: 50.5M Q3 '18: 50.6M Q1 '21: 1.6M Q2 '21: 2M Q3 '21: 2M Q1 '22: 2M Q2 '22: 2M Q3 '22: 518.1K Q1 '23: 518.1K Q2 '23: 518.1K Q3 '23: 3.8M Q1 '24: 6.2M Q2 '24: 8.7M Q3 '24: 8.7M Q1 '25: 8.7M Q2 '25: 9M Q3 '25: 9.3M Q1 '26: 9.3M Q2 '26: 10.2M Q3 '11 Q2 '13 Q1 '15 Q2 '17 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-45.00 -30.00 -15.00 0.00 15.00 30.00 45.00 Q4 '10: -0.14 Q1 '11: -0.13 Q2 '11: -0.13 Q3 '11: -0.16 Q4 '11: -0.26 Q1 '12: -0.24 Q2 '12: -0.23 Q3 '12: -0.21 Q4 '12: -7.96 Q1 '13: -10.87 Q2 '13: -10.03 Q3 '13: -10.36 Q4 '13: -1.00 Q1 '14: 1.68 Q2 '14: 0.51 Q3 '14: 0.70 Q4 '14: -1.00 Q1 '15: -0.83 Q2 '15: -0.54 Q3 '16: -2.27 Q4 '16: -1.76 Q1 '17: -3.92 Q2 '17: -4.55 Q3 '17: -3.82 Q4 '17: -30.86 Q3 '22: -7.60 Q4 '23: -0.82 Q1 '24: -0.20 Q2 '24: 2.28 Q3 '24: 2.43 Q4 '24: -2.03 Q1 '25: -2.18 Q2 '25: -2.61 Q3 '25: -2.90 Q4 '25: -2.98 Q1 '26: -3.28 Q2 '26: -3.22 Q1 '11 Q2 '12 Q3 '13 Q4 '14 Q1 '17 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.